Global Insomnia
Market Report
2024
Insomnia Market Report 2024 (Global Edition)
The global insomnia market size is USD 5.7 billion in 2024. The insomnia market will show strongest growth with a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031. The rise in mental depression and other painful illnesses, together with the prevalence of various sleep disorders including insomnia and parasomnias, are the main factors driving the growth of the worldwide insomnia market.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
| Share your contact details to receive free updated sample copy/pages of the recently published edition of Insomnia Market Report 2024.
Global Insomnia Market Report 2024 Market Size Split by Treatment Type (Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonist, Melatonin Antagonist, Dev...
According to Cognitive Market Research, the global insomnia market size is USD 5.7 billion in 2024 and will expand at a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031.
| Base Year | 2023 |
| Historical Data Time Period | 2019-2023 |
| Forecast Period | 2024-2031 |
| Global Insomnia Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 4.2% |
| Market Split by Treatment Type |
|
| Market Split by Sales Channel |
|
| List of Competitors |
|
| Regional Analysis |
|
Country Analysis |
|
Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of Insomnia industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Insomnia Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Insomnia Market Report Description
Introduction of the Insomnia Market
A sleep problem called insomnia can deplete a person's energy and have an impact on their mood, general well-being, productivity at work, and general quality of life. Stress, extended travel, busy work schedules, irregular sleep patterns, binge eating, and excessive use of alcohol, caffeine, and nicotine are among its frequent causes. It may also be linked to mental health conditions like post-traumatic stress disorder and the use of over-the-counter (OTC) medications for pain, allergies, and colds as well as antidepressants for blood pressure and asthma. Factors supporting the growth of the insomnia therapeutics market include increasing stress levels, patentable compounds in the market, potential medications in the clinical pipeline, the introduction of technologically improved medical devices, and an aging population.
Market Dynamics of Insomnia Market
Key Drivers for Insomnia Market
- Increase in the Aging Population is Fueling the Growth of the Insomnia Market - Both acute and chronic sleeplessness are common in most older people globally. Most older persons struggle with maintaining sleep patterns. In these people, managing sleep disturbances is complicated and necessitates continuing therapy as well as a close assessment of any underlying medical issues. As a result, the industry that deals with insomnia is expanding due to the ageing population. Male patient morbidity and mortality, as well as an increased chance of being placed in a nursing home, are linked to sleep deprivation. For older people, a variety of rehabilitative care options are available. Future growth in the insomnia industry is anticipated to be fueled by research and development of new medications. The U.S. Food and Drug Administration finally gave Zydus Lifesciences permission in December 2022 to sell 0.125 mg and 0.25 mg tablets of triazolam for the short-term treatment of insomnia.
- Over the course of the projected period, rising healthcare expenses and earlier disease detection as a result of greater awareness of available treatments are key drivers anticipated to propel market expansion.
Key Restraints for Insomnia Market
- During the course of the projection period, patient non-adherence to therapy and misconceptions about the severity of insomnia are projected to hinder market growth.
- The underdeveloped economies' weak healthcare infrastructure and scarcity of qualified medical personnel are further impeding the market's rate of growth.
We have various report editions of Insomnia Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Insomnia Market Insights Video
May 2023: Researchers found that sleep medications, which are commonly used to treat insomnia or trouble falling and staying asleep, dramatically lower rapid eye movement (REM) sleep behavior disorder. Furthermore, these medications—often referred to as dual orexin receptor antagonists—would have fewer adverse effects, according to the study's findings. (Source: https://www.mountsinai.org/about/newsroom/2023/mount-sinai-researchers-identify-potential-new-treatment-for-those-who-act-out-their-dreams-while-sleeping )
Top Companies Market Share in Insomnia Industry: (In no particular order of Rank)
- MINERVA NEUROSCIENCES INC
- Sanofi
- EISAI
- CO. LTD
- VIATRIS INC
- Vanda Pharmaceuticals Inc.
- Takeda Pharmaceutical Company Ltd
- Merck KGAa
- Darmstadt Germany
- Zydus Cadila
- Pfizer Inc.
- CURRAX PHARMACEUTICALS LLC
- Others
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
Regional Analysis of Insomnia Market
Which Region Dominates the Insomnia Market in 2024?
According to Cognitive Market Research, North America dominated the market in 2024 and accounted for around 40% of the global revenue. It is expected that the market growth rate will soar due to the growing need for sleep disorder treatment in both the US & Canada, as well as the increased prevalence of sleep disorders. In addition, the influence of depression, obesity, hypertension, cancer, and numerous other diseases that are increasingly common in this area is also contributing to the growth in sleep-related disorders. Additionally, the region's well-established healthcare system and greater rate of work-related stress are probably going to fuel market expansion.
Which Region is Expanding at the Fastest CAGR?
Asia-Pacific stands out as the fastest-growing region in the insomnia market. The region's market expansion could be attributed in large part to the working population's elevated stress levels and sleep difficulties associated with shift work. The region's governments are constantly striving to enhance their healthcare programs and offer favorable reimbursement guidelines, which could have an effect on the market for insomnia in the area. The need for medical facilities and sleep aids is expected to rise in developing nations like China & India over the next few years.
The current report Scope analyzes Insomnia Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
- Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
Insomnia Market Share (%) by Region (2019-2031)
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Insomnia Market Analysis
Global Insomnia Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Insomnia Industry growth. Insomnia market has been segmented with the help of its Treatment Type, Sales Channel , and others. Insomnia market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
Treatment Type Segment Analysis of Insomnia Market
Based on present and future trends, the market size is estimated from 2019 to 2031. Moreover, study also provides quantitative and qualitative analysis of each type to understand the driving factors for the fastest growing type segment for Insomnia market.
Treatment Type of Insomnia analyzed in this report are as follows:
- Benzodiazepines
- Nonbenzodiazepines
- Antidepressants
- Orexin Antagonist
- Melatonin Antagonist
- Devices
- Others
Insomnia Market Share (%) by Treatment Type in 2019-2031
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Insomnia Industry. Request a Free Sample PDF!
Insomnia Market Sales Channel Segment Analysis
According to cognitive market research, hospitals pharmacies are the dominant category. This substantial portion is mostly due to people becoming more conscious of their sleeplessness. The rise in the use of prescription medications is largely driving the growth of the segment. Because many different disorders and variables can cause insomnia, it must be addressed under the guidance of a medical practitioner. For this ailment, the medication must be given at a precise frequency and time. As a result, most medications for this illness can only be obtained with a prescription from a physician. Hospital pharmacies, as a result, guarantee the high availability of these medications, helping the segment's revenue growth.
Insomnia Market Share (%) by Sales Channel in 2019-2031
2019
2023
2031
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Author's Detail
Anushka GoreResearch Associate at Cognitive Market Research
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the medical devices & consumables industry. She has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services. Her expertise in Market Research and business intelligence has equipped her with the skills necessary to analyze complex information and provide strategic recommendations.
In her current role, Anushka is a highly motivated and detail-oriented research analyst with a passion for uncovering valuable insights from data. She thrives in dynamic environments where her analytical abilities and research expertise can contribute to informed decision-making for businesses. Her collaborative approach facilitated effective communication of insights, fostering a data-driven culture within the organization.Anushka remains an invaluable asset in the dynamic landscape of market research.
Author's Conclusion
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Insomnia Market is witnessing significant growth in the near future.
In 2023, the Benzodiazepines segment accounted for noticeable share of global Insomnia Market and is projected to experience significant growth in the near future.
The Hospital Pharmacies segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies MINERVA NEUROSCIENCES INC , EISAI and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Frequently Asked Questions
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Latest News about Insomnia Market
Sources from Medical Devices & Consumables Industry
- http://www.trade.gov
- http://www.gov.uk
- http://www.fda.gov
- http://www.hhs.gov
- http://www.who.int
- http://www.bls.gov
- http://www.gao.gov
- http://www.ncbi.nlm.nih.gov
- http://www.healthcaredive.com
- http://www.weforum.org
- http://www.health.gov.za
- http://www.usaid.gov
- http://www.eumdr.com
- http://www.cdc.gov
- http://www.ama-assn.org
- http://www.washingtonpost.com
- http://www.ecfr.gov
- http://www.hbr.org
- http://www.worldbank.org
- http://www.commission.europa.eu
- http://www.cbi.eu
- http://www.unicef.org
- http://www.ecipe.org
- http://www.ema.europa.eu
Insomnia Market Report Table of Content
Disclaimer:
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
| Treatment Type | Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonist, Melatonin Antagonist, Devices, Others |
| Sales Channel | Hospital Pharmacies, Retail Pharmacies and Drug Stores, Online Pharmacies |
| List of Competitors | MINERVA NEUROSCIENCES INC, Sanofi, EISAI, CO. LTD, VIATRIS INC, Vanda Pharmaceuticals Inc., Takeda Pharmaceutical Company Ltd, Merck KGAa, Darmstadt Germany, Zydus Cadila, Pfizer Inc., CURRAX PHARMACEUTICALS LLC, Others |
This chapter will help you gain GLOBAL Market Analysis of Insomnia. Further deep in this chapter, you will be able to review Global Insomnia Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
-
1.1 Global Insomnia Market Size, Trend Analysis 2019 - 2031
-
1.2 Global Insomnia Market Size By Regions 2019 - 2031
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
-
1.2.1 Global Insomnia Revenue Market Size By Region
-
-
1.3 Global Insomnia Market Size By Treatment Type 2019 -2031
-
1.3.1 Benzodiazepines Market Size
-
1.3.2 Nonbenzodiazepines Market Size
-
1.3.3 Antidepressants Market Size
-
1.3.4 Orexin Antagonist Market Size
-
1.3.5 Melatonin Antagonist Market Size
-
1.3.6 Devices Market Size
-
1.3.7 Others Market Size
-
-
1.4 Global Insomnia Market Size By Sales Channel 2019 -2031
-
1.4.1 Hospital Pharmacies Market Size
-
1.4.2 Retail Pharmacies and Drug Stores Market Size
-
1.4.3 Online Pharmacies Market Size
-
-
1.5 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
-
1.6 Executive Summary Global Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
-
1.6.1 Regional Market Revenue Summary 2019 vs 2024 vs 2031
-
1.6.2 Global Market Revenue Split By Treatment Type
-
1.6.3 Global Market Revenue Split By Sales Channel
-
1.6.4 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
-
Chapter 2 North America Market Analysis
-
2.1 North America Insomnia Market Size 2019 - 2031
-
2.1.1 North America Insomnia Market Size By Country 2019 - 2031
-
2.1.2 North America Insomnia Market Size by Treatment Type 2019 -2031
-
2.1.2.1 North America Benzodiazepines Market Size
-
2.1.2.2 North America Nonbenzodiazepines Market Size
-
2.1.2.3 North America Antidepressants Market Size
-
2.1.2.4 North America Orexin Antagonist Market Size
-
2.1.2.5 North America Melatonin Antagonist Market Size
-
2.1.2.6 North America Devices Market Size
-
2.1.2.7 North America Others Market Size
-
-
2.1.3 North America Insomnia Market Size by Sales Channel 2019 -2031
-
2.1.3.1 North America Hospital Pharmacies Market Size
-
2.1.3.2 North America Retail Pharmacies and Drug Stores Market Size
-
2.1.3.3 North America Online Pharmacies Market Size
-
-
Chapter 3 Europe Market Analysis
-
3.1 Europe Insomnia Market Size 2019 - 2031
-
3.1.1 Europe Insomnia Market Size By Country 2019 - 2031
-
3.1.2 Europe Insomnia Market Size by Treatment Type 2019 -2031
-
3.1.2.1 Europe Benzodiazepines Market Size
-
3.1.2.2 Europe Nonbenzodiazepines Market Size
-
3.1.2.3 Europe Antidepressants Market Size
-
3.1.2.4 Europe Orexin Antagonist Market Size
-
3.1.2.5 Europe Melatonin Antagonist Market Size
-
3.1.2.6 Europe Devices Market Size
-
3.1.2.7 Europe Others Market Size
-
-
3.1.3 Europe Insomnia Market Size by Sales Channel 2019 -2031
-
3.1.3.1 Europe Hospital Pharmacies Market Size
-
3.1.3.2 Europe Retail Pharmacies and Drug Stores Market Size
-
3.1.3.3 Europe Online Pharmacies Market Size
-
-
Chapter 4 Asia Pacific Market Analysis
-
4.1 Asia Pacific Insomnia Market Size 2019 - 2031
-
4.1.1 Asia Pacific Insomnia Market Size By Country 2019 - 2031
-
4.1.2 Asia Pacific Insomnia Market Size by Treatment Type 2019 -2031
-
4.1.2.1 Asia Pacific Benzodiazepines Market Size
-
4.1.2.2 Asia Pacific Nonbenzodiazepines Market Size
-
4.1.2.3 Asia Pacific Antidepressants Market Size
-
4.1.2.4 Asia Pacific Orexin Antagonist Market Size
-
4.1.2.5 Asia Pacific Melatonin Antagonist Market Size
-
4.1.2.6 Asia Pacific Devices Market Size
-
4.1.2.7 Asia Pacific Others Market Size
-
-
4.1.3 Asia Pacific Insomnia Market Size by Sales Channel 2019 -2031
-
4.1.3.1 Asia Pacific Hospital Pharmacies Market Size
-
4.1.3.2 Asia Pacific Retail Pharmacies and Drug Stores Market Size
-
4.1.3.3 Asia Pacific Online Pharmacies Market Size
-
-
Chapter 5 South America Market Analysis
-
5.1 South America Insomnia Market Size 2019 - 2031
-
5.1.1 South America Insomnia Market Size By Country 2019 - 2031
-
5.1.2 South America Insomnia Market Size by Treatment Type 2019 -2031
-
5.1.2.1 South America Benzodiazepines Market Size
-
5.1.2.2 South America Nonbenzodiazepines Market Size
-
5.1.2.3 South America Antidepressants Market Size
-
5.1.2.4 South America Orexin Antagonist Market Size
-
5.1.2.5 South America Melatonin Antagonist Market Size
-
5.1.2.6 South America Devices Market Size
-
5.1.2.7 South America Others Market Size
-
-
5.1.3 South America Insomnia Market Size by Sales Channel 2019 -2031
-
5.1.3.1 South America Hospital Pharmacies Market Size
-
5.1.3.2 South America Retail Pharmacies and Drug Stores Market Size
-
5.1.3.3 South America Online Pharmacies Market Size
-
-
Chapter 6 Middle East and Africa Market Analysis
-
6.1 Middle East and Africa Insomnia Market Size 2019 - 2031
-
6.1.1 Middle East and Africa Insomnia Market Size By Country 2019 - 2031
-
6.1.2 Middle East and Africa Insomnia Market Size by Treatment Type 2019 -2031
-
6.1.2.1 Middle East and Africa Benzodiazepines Market Size
-
6.1.2.2 Middle East and Africa Nonbenzodiazepines Market Size
-
6.1.2.3 Middle East and Africa Antidepressants Market Size
-
6.1.2.4 Middle East and Africa Orexin Antagonist Market Size
-
6.1.2.5 Middle East and Africa Melatonin Antagonist Market Size
-
6.1.2.6 Middle East and Africa Devices Market Size
-
6.1.2.7 Middle East and Africa Others Market Size
-
-
6.1.3 Middle East and Africa Insomnia Market Size by Sales Channel 2019 -2031
-
6.1.3.1 Middle East and Africa Hospital Pharmacies Market Size
-
6.1.3.2 Middle East and Africa Retail Pharmacies and Drug Stores Market Size
-
6.1.3.3 Middle East and Africa Online Pharmacies Market Size
-
-
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis (Only Available with Corporate User License)
-
7.1 Country 1 Market Analysis
-
7.1.1 Country 1Insomnia Market Size by Treatment Type 2019 -2031
-
7.1.2 Country 1Insomnia Market Size by Sales Channel 2019 -2031
-
-
7.2 Country 2 Market Analysis
-
7.2.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.3 Country 3 Market Analysis
-
7.3.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.4 Country 4 Market Analysis
-
7.4.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.5 Country 5 Market Analysis
-
7.5.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.6 Country 6 Market Analysis
-
7.6.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.7 Country 7 Market Analysis
-
7.7.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.8 Country 8 Market Analysis
-
7.8.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.9 Country 9 Market Analysis
-
7.9.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.10 Country 10 Market Analysis
-
7.10.1 Segmentation Analysis will be provided as shown for Country 1
-
Competitor's Market Share and Revenue (Subject to Data Availability for Private Players)
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
-
8.1 Top Competitors Analysis
-
8.1.1 Top Players Ranking 2022
-
8.1.2 Global Insomnia Market Revenue and Share by Manufacturers (2019-2023)
(Subject to Data Availability (Private Players))
-
8.1.3 Industry Mergers and Acquisition Analysis
-
8.1.4 New Product Launch Analysis
-
-
8.2 Company Profile (Data Subject to Availability)
-
8.2.1 MINERVA NEUROSCIENCES INC
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.1.2 Business Overview
-
8.2.1.3 Financials (Subject to data availability)
-
8.2.1.4 Product Types Specification
-
8.2.1.5 Business Strategy
-
8.2.1.6 S.W.O.TAnalysis
-
-
8.2.2 Sanofi
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.2.2 Business Overview
-
8.2.2.3 Financials (Subject to data availability)
-
8.2.2.4 Product Types Specification
-
8.2.2.5 Business Strategy
-
8.2.2.6 S.W.O.TAnalysis
-
-
8.2.3 EISAI
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.3.2 Business Overview
-
8.2.3.3 Financials (Subject to data availability)
-
8.2.3.4 Product Types Specification
-
8.2.3.5 Business Strategy
-
8.2.3.6 S.W.O.TAnalysis
-
-
8.2.4 CO. LTD
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.4.2 Business Overview
-
8.2.4.3 Financials (Subject to data availability)
-
8.2.4.4 Product Types Specification
-
8.2.4.5 Business Strategy
-
8.2.4.6 S.W.O.TAnalysis
-
-
8.2.5 VIATRIS INC
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.5.2 Business Overview
-
8.2.5.3 Financials (Subject to data availability)
-
8.2.5.4 Product Types Specification
-
8.2.5.5 Business Strategy
-
8.2.5.6 S.W.O.TAnalysis
-
-
8.2.6 Vanda Pharmaceuticals Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.6.2 Business Overview
-
8.2.6.3 Financials (Subject to data availability)
-
8.2.6.4 Product Types Specification
-
8.2.6.5 Business Strategy
-
8.2.6.6 S.W.O.TAnalysis
-
-
8.2.7 Takeda Pharmaceutical Company Ltd
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.7.2 Business Overview
-
8.2.7.3 Financials (Subject to data availability)
-
8.2.7.4 Product Types Specification
-
8.2.7.5 Business Strategy
-
8.2.7.6 S.W.O.TAnalysis
-
-
8.2.8 Merck KGAa
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.8.2 Business Overview
-
8.2.8.3 Financials (Subject to data availability)
-
8.2.8.4 Product Types Specification
-
8.2.8.5 Business Strategy
-
8.2.8.6 S.W.O.TAnalysis
-
-
8.2.9 Darmstadt Germany
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.9.2 Business Overview
-
8.2.9.3 Financials (Subject to data availability)
-
8.2.9.4 Product Types Specification
-
8.2.9.5 Business Strategy
-
8.2.9.6 S.W.O.TAnalysis
-
-
8.2.10 Zydus Cadila
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.10.2 Business Overview
-
8.2.10.3 Financials (Subject to data availability)
-
8.2.10.4 Product Types Specification
-
8.2.10.5 Business Strategy
-
8.2.10.6 S.W.O.TAnalysis
-
-
8.2.11 Pfizer Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.11.2 Business Overview
-
8.2.11.3 Financials (Subject to data availability)
-
8.2.11.4 Product Types Specification
-
8.2.11.5 Business Strategy
-
8.2.11.6 S.W.O.TAnalysis
-
-
8.2.12 CURRAX PHARMACEUTICALS LLC
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.12.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.12.2 Business Overview
-
8.2.12.3 Financials (Subject to data availability)
-
8.2.12.4 Product Types Specification
-
8.2.12.5 Business Strategy
-
8.2.12.6 S.W.O.TAnalysis
-
-
8.2.13 Others
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.13.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.13.2 Business Overview
-
8.2.13.3 Financials (Subject to data availability)
-
8.2.13.4 Product Types Specification
-
8.2.13.5 Business Strategy
-
8.2.13.6 S.W.O.TAnalysis
-
-
Chapter 9 Qualitative Analysis (Subject to Data Availability)
-
9.1 Market Drivers
-
9.2 Market Trends
-
9.3 Market Restraints
-
9.4 Market Opportunity
-
9.5 Product Life Cycle (Subject to Data Availability)
-
9.6 Industrial Chain Analysis (Subject to Data Availability)
-
9.6.1 Industry Chain Analysis
-
9.6.2 Manufacturing Cost Analysis
-
9.6.3 Consumer Preference Analysis
-
9.6.4 Supply Side Analysis
-
9.6.4.1 Raw Material Analysis
-
9.6.4.2 Raw Material Procurement Analysis
-
9.6.4.3 Raw Material Price Trend Analysis
-
-
-
9.7 Market Attractiveness Analysis
-
9.8 PESTEL Analysis
-
9.9 Porter’s Five Forces Analysis
-
9.10 Patent Analysis (Subject to Data Availability)
-
9.11 ESG Analysis
-
9.12 Technological Road Map
Segmentation Treatment Type Analysis 2019 -2031, will provide market size split by Treatment Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Treatment Type Analysis 2019 -2031
-
10.1 Benzodiazepines
-
10.1.1 Global Insomnia Revenue Market Size and Share by Benzodiazepines 2019 -2031
-
-
10.2 Nonbenzodiazepines
-
10.2.1 Global Insomnia Revenue Market Size and Share by Nonbenzodiazepines 2019 -2031
-
-
10.3 Antidepressants
-
10.3.1 Global Insomnia Revenue Market Size and Share by Antidepressants 2019 -2031
-
-
10.4 Orexin Antagonist
-
10.4.1 Global Insomnia Revenue Market Size and Share by Orexin Antagonist 2019 -2031
-
-
10.5 Melatonin Antagonist
-
10.5.1 Global Insomnia Revenue Market Size and Share by Melatonin Antagonist 2019 -2031
-
-
10.6 Devices
-
10.6.1 Global Insomnia Revenue Market Size and Share by Devices 2019 -2031
-
-
10.7 Others
-
10.7.1 Global Insomnia Revenue Market Size and Share by Others 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Sales Channel Analysis 2019 -2031
-
11.1 Hospital Pharmacies
-
11.1.1 Global Insomnia Revenue Market Size and Share by Hospital Pharmacies 2019 - 2031
-
-
11.2 Retail Pharmacies and Drug Stores
-
11.2.1 Global Insomnia Revenue Market Size and Share by Retail Pharmacies and Drug Stores 2019 - 2031
-
-
11.3 Online Pharmacies
-
11.3.1 Global Insomnia Revenue Market Size and Share by Online Pharmacies 2019 - 2031
-
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Insomnia market
Chapter 12 Research Findings
-
12.1 Key Takeaways
-
12.2 Analyst Point of View
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
-
12.3 Assumptions and Acronyms
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Qualitative Analysis
Research Methodology Implemented by Anushka Gore and Team
- 1.1 Insomnia Market Report 2024 Research Methodology
- 1.2 Systematic Research Approach
- 1.2.1 Primary Research for Insomnia Market
- 1.2.1.1 Key Data from Primary
- 1.2.1.2 Primary Interviews with Experts
- 1.2.1.3 Key Industry Insights
- 1.2.1.4 Questionnaire for Insomnia Market
- 1.2.1.5 Breakdown of Primaries
- 1.2.2 Secondary Research for Insomnia Market
- 1.2.2.1 Key Data from Secondary
- 1.2.2.2 Paid Sources
- 1.2.2.3 Public Sources
- 1.3 Market Size Estimation for Insomnia Market
- 1.3.1 Top-Down Approach
- 1.3.1.1 Analyzing Market Size by Top-Down Approach (Supply Side)
- 1.3.2 Bottom-UP Approach
- 1.3.2.1 Analyzing Market Size by Bottom-Up Approach (Demand Side)
- 1.3.1 Top-Down Approach
- 1.4 Market Breakdown and Data Triangulation
- 1.5 Research Assumptions for Insomnia Market
Key Questions Answered By Insomnia Market Report 2024
| Why Benzodiazepines have a significant impact on Insomnia market? |
| What are the key factors affecting the Benzodiazepines and Nonbenzodiazepines of Insomnia Market? |
| What is the CAGR/Growth Rate of Hospital Pharmacies during the forecast period? |
| By type, which segment accounted for largest share of the global Insomnia Market? |
| Which region is expected to dominate the global Insomnia Market within the forecast period? |
| Segmentation Level Customization |
|
| Global level Data Customization |
|
| Region level Data Customization |
|
| Country level Data Customization |
|
| Company Level |
|
| Additional Data Analysis |
|
| Additional Qualitative Data |
|
| Additional Quantitative Data |
|
| Service Level Customization |
|
Report Format Alteration |
|
